Mesenchymal stromal cell therapy alone does not lead to complete restoration of skin parameters in diabetic foot patients within a 3-year follow-up period

[Image: see text] Introduction: Mesenchymal stromal cells (MSCs) administration is an effective option for the treatment of diabetic foot ulcers (DFUs). However, to date, studies assessing long-term outcomes and evaluating skin parameters after cell-based therapy are lacking. We presented the clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Maksimova, Nadezhda V., Michenko, Anna V., Krasilnikova, Olga A., Klabukov, Ilya D., Gadaev, Igor Yu., Krasheninnikov, Michael E., Belkov, Pavel A., Lyundup, Aleksey V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences (TUOMS Publishing Group) 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783077/
https://www.ncbi.nlm.nih.gov/pubmed/35087716
http://dx.doi.org/10.34172/bi.2021.22167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783077/
https://www.ncbi.nlm.nih.gov/pubmed/35087716
http://dx.doi.org/10.34172/bi.2021.22167

Ejemplares similares